DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi

Volume: 6 Number: 3 September 1, 2012
  • Uğur Bilge
TR EN

DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi

Abstract

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Uğur Bilge This is me

Publication Date

September 1, 2012

Submission Date

August 1, 2014

Acceptance Date

-

Published in Issue

Year 2012 Volume: 6 Number: 3

APA
Bilge, U. (2012). DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi. Turkish Journal of Family Medicine and Primary Care, 6(3). https://izlik.org/JA95FY59YP
AMA
1.Bilge U. DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi. TJFMPC. 2012;6(3). https://izlik.org/JA95FY59YP
Chicago
Bilge, Uğur. 2012. “DPP-4 İnhibitörleri Ve Diabetes Mellitus Tedavisi”. Turkish Journal of Family Medicine and Primary Care 6 (3). https://izlik.org/JA95FY59YP.
EndNote
Bilge U (September 1, 2012) DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi. Turkish Journal of Family Medicine and Primary Care 6 3
IEEE
[1]U. Bilge, “DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi”, TJFMPC, vol. 6, no. 3, Sept. 2012, [Online]. Available: https://izlik.org/JA95FY59YP
ISNAD
Bilge, Uğur. “DPP-4 İnhibitörleri Ve Diabetes Mellitus Tedavisi”. Turkish Journal of Family Medicine and Primary Care 6/3 (September 1, 2012). https://izlik.org/JA95FY59YP.
JAMA
1.Bilge U. DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi. TJFMPC. 2012;6. Available at https://izlik.org/JA95FY59YP.
MLA
Bilge, Uğur. “DPP-4 İnhibitörleri Ve Diabetes Mellitus Tedavisi”. Turkish Journal of Family Medicine and Primary Care, vol. 6, no. 3, Sept. 2012, https://izlik.org/JA95FY59YP.
Vancouver
1.Uğur Bilge. DPP-4 İnhibitörleri ve Diabetes Mellitus Tedavisi. TJFMPC [Internet]. 2012 Sep. 1;6(3). Available from: https://izlik.org/JA95FY59YP

English or Turkish manuscripts from authors with new knowledge to contribute to understanding and improving health and primary care are welcome. 


Turkish Journal of Family Medicine and Primary Care © 2024 by Academy of Family Medicine Association is licensed under CC BY-NC-ND 4.0